Oxandrolonum
Oxandrolonum Uses, Dosage, Side Effects, Food Interaction and all others data.
A synthetic hormone with anabolic and androgenic properties.
Oxandrolonum is an anabolic steroids indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in some patients who without definite pathophysiologic reasons fail to gain or to maintain normal weight, to offset the protein catabolism associated with prolonged administration of corticosteroids, and for the relief of the bone pain frequently accompanying osteoporosis. Anabolic steroids are synthetic derivatives of testosterone.
| Trade Name | Oxandrolonum |
| Availability | Prescription only |
| Generic | Oxandrolone |
| Oxandrolone Other Names | Ossandrolone, Oxandrolon, Oxandrolona, Oxandrolone, Oxandrolonum |
| Related Drugs | phentermine, Victoza, Saxenda, liraglutide, Contrave, propylthiouracil, Qsymia, Genotropin, Norditropin, somatropin |
| Type | |
| Formula | C19H30O3 |
| Weight | Average: 306.4397 Monoisotopic: 306.219494826 |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Oxandrolonum is an androgenic hormone used to treat muscle loss from prolonged corticosteroid treatment and to treat bone pain associated with osteoporosis.
Use to promote weight gain after weight loss following extensive surgery.
Oxandrolonum is also used to associated treatment for these conditions: Amino acid catabolism disorder, Pain, Weight Gain
How Oxandrolonum works
Oxandrolonums interact with androgen receptors in target tissues.
Toxicity
The oral LD50 of oxandrolone in mice and dogs is greater than 5,000 mg/kg.
Food Interaction
No interactions found.Oxandrolonum Cholesterol interaction
[Major] Androgenic anabolic steroids may adversely affect serum lipids, including lowering HDL and elevating LDL levels.
These changes can be marked, particularly with the 17-alpha-alkyl derivatives (i.e., fluoxymesterone, methyltestosterone, oxandrolone, oxymetholone, and stanozolol), and may significantly impact the risk of atherosclerosis and coronary artery disease.
Patients with preexisting hyperlipoproteinemia may require closer monitoring during therapy with androgenic agents, and adjustments made accordingly in their lipid-lowering regimen.
Androgen therapy should be administered cautiously in patients with coronary artery disease or a history of ischemic heart disease.
Oxandrolonum Drug Interaction
Unknown: 5-hydroxytryptophan, amphetamine / dextroamphetamine, zolpidem, anastrozole, lorazepam, tadalafil, dehydroepiandrosterone, omega-3 polyunsaturated fatty acids, chorionic gonadotropin , arginine, acetylcysteine, esomeprazole, emtricitabine / tenofovir, valacyclovir, sildenafil, cyanocobalamin, ascorbic acid, cholecalciferol, alprazolam, sertraline
Half Life
0.55 hours (1st phage), 9 hours (2nd phase)
Innovators Monograph
You find simplified version here Oxandrolonum
